CLS.TO vs. HCA
CLS.TO (Celestica Inc.) and HCA (HCA Healthcare, Inc.) are both stocks. CLS.TO operates in Electronic Components (Technology), while HCA operates in Medical Care Facilities (Healthcare). Over the past 10 years, CLS.TO returned 44.95%/yr vs 19.30%/yr for HCA. At a 0.20 correlation, their price movements are largely independent.
Performance
CLS.TO vs. HCA - Performance Comparison
Loading charts...
Different Trading Currencies
CLS.TO is traded in CAD, while HCA is traded in USD. To make them comparable, the HCA values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CLS.TO achieves a 35.52% return, which is significantly higher than HCA's -15.17% return. Over the past 10 years, CLS.TO has outperformed HCA with an annualized return of 44.95%, while HCA has yielded a comparatively lower 19.30% annualized return.
CLS.TO
- 1D
- 2.22%
- 1M
- 7.85%
- YTD
- 35.52%
- 6M
- 30.45%
- 1Y
- 209.23%
- 3Y*
- 212.27%
- 5Y*
- 122.50%
- 10Y*
- 44.95%
HCA
- 1D
- 2.59%
- 1M
- -7.52%
- YTD
- -15.17%
- 6M
- -18.66%
- 1Y
- 7.34%
- 3Y*
- 14.02%
- 5Y*
- 17.15%
- 10Y*
- 19.30%
CLS.TO vs. HCA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLS.TO Celestica Inc. | 35.52% | 206.05% | 241.82% | 154.33% | 8.23% | 37.29% | -4.64% | -9.95% | -9.26% | -17.16% |
HCA HCA Healthcare, Inc. | -15.17% | 49.55% | 21.22% | 11.13% | 0.34% | 57.50% | 9.41% | 15.29% | 55.43% | 10.64% |
Correlation
The correlation between CLS.TO and HCA is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Mar 10, 2011 | 0.20 |
The correlation between CLS.TO and HCA shifts across timeframes, from 0.05 (1 year) to 0.21 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
CLS.TO:
$8.28
HCA:
$28.46
CLS.TO:
47.51
HCA:
13.60
CLS.TO:
0.64
HCA:
1.62
CLS.TO:
3.30
HCA:
1.22
CLS.TO:
$13.81B
HCA:
$75.60B
CLS.TO:
$1.60B
HCA:
$31.37B
CLS.TO:
$1.36B
HCA:
$15.60B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLS.TO vs. HCA — Risk / Return Rank
CLS.TO
HCA
CLS.TO vs. HCA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Celestica Inc. (CLS.TO) and HCA Healthcare, Inc. (HCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLS.TO | HCA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.67 | ||
| Sortino ratioReturn per unit of downside risk | +2.33 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.07 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 6.64 | 0.23 | +6.41 |
| Martin ratioReturn relative to average drawdown | 16.31 | 0.66 | +15.65 |
Loading charts...
Drawdowns
CLS.TO vs. HCA - Drawdown Comparison
The maximum CLS.TO drawdown since its inception was -79.32%, which is greater than HCA's maximum drawdown of -51.48%. Use the drawdown chart below to compare losses from any high point for CLS.TO and HCA.
Loading charts...
Drawdown Indicators
| CLS.TO | HCA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.32% | -51.48% | -27.84% |
Max Drawdown (1Y)Largest decline over 1 year | -31.71% | -32.37% | +0.66% |
Max Drawdown (3Y)Largest decline over 3 years | -54.25% | -32.37% | -21.88% |
Max Drawdown (5Y)Largest decline over 5 years | -54.25% | -37.42% | -16.83% |
Max Drawdown (10Y)Largest decline over 10 years | -79.32% | -51.48% | -27.84% |
Current DrawdownCurrent decline from peak | -15.72% | -27.15% | +11.43% |
Average DrawdownAverage peak-to-trough decline | -28.84% | -10.32% | -18.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.89% | 11.13% | +1.76% |
Volatility
CLS.TO vs. HCA - Volatility Comparison
Celestica Inc. (CLS.TO) has a higher volatility of 27.86% compared to HCA Healthcare, Inc. (HCA) at 9.14%. This indicates that CLS.TO's price experiences larger fluctuations and is considered to be riskier than HCA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLS.TO | HCA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.86% | 9.14% | +18.72% |
Volatility (6M)Calculated over the trailing 6-month period | 55.27% | 21.78% | +33.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.69% | 27.88% | +43.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.60% | 30.39% | +26.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.83% | 33.11% | +15.72% |
Dividends
CLS.TO vs. HCA - Dividend Comparison
CLS.TO has not paid dividends to shareholders, while HCA's dividend yield for the trailing twelve months is around 0.76%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
CLS.TO Celestica Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HCA HCA Healthcare, Inc. | 0.76% | 0.62% | 0.88% | 0.89% | 0.93% | 0.75% | 0.63% | 1.08% | 1.12% |
Financials
CLS.TO vs. HCA - Financials Comparison
This section allows you to compare key financial metrics between Celestica Inc. and HCA Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLS.TO vs. HCA - Profitability Comparison
CLS.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
HCA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a gross profit of 8.18B and revenue of 19.51B. Therefore, the gross margin over that period was 41.9%.
CLS.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 267.70M and revenue of 4.05B, resulting in an operating margin of 6.6%.
HCA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported an operating income of 3.18B and revenue of 19.51B, resulting in an operating margin of 16.3%.
CLS.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
HCA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a net income of 1.88B and revenue of 19.51B, resulting in a net margin of 9.6%.
Frequently Asked Questions
CLS.TO and HCA have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CLS.TO and HCA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer